Clinical Trials Logo

Filter by:
NCT ID: NCT04161794 Completed - Cachexia; Cancer Clinical Trials

Multimodal Intervention for Patients With Non-small Cell Lung Cancer

Start date: February 15, 2018
Phase: N/A
Study type: Interventional

A single-arm intervention study assessing the feasibility of a multimodal intervention of management of cancer cachexia in patients with non-small cell lung cancer during primary anti-neoplastic treatment. The effects of the intervention is compared to a historical control group

NCT ID: NCT04158986 Completed - Liver Cirrhosis Clinical Trials

Nurse Assisted Post-discharge Intervention in Decompensated Cirrhosis

NurseAID
Start date: December 1, 2019
Phase: N/A
Study type: Interventional

In a randomized controlled trial, the effects of a nurse-driven post-discharge intervention for patients with liver cirrhosis compared with standard follow-up will be investigated.

NCT ID: NCT04157751 Completed - Heart Failure Clinical Trials

A Study to Test the Effect of Empagliflozin in Patients Who Are in Hospital for Acute Heart Failure

Start date: May 18, 2020
Phase: Phase 3
Study type: Interventional

This is a study in adults who are in hospital for acute heart failure. The purpose of this study is to find out whether starting to take a medicine called empagliflozin soon after first being treated in hospital helps people with acute heart failure. Participants are in the study for about 3 months. At the beginning, participants are still in hospital. Later, they visit the hospital about 3 times and get 1 phone call. Participants are put into 2 groups by chance. One group takes 1 empagliflozin tablet a day. The other group takes 1 placebo tablet a day. Placebo tablets look like empagliflozin tablets but do not contain any medicine. Empagliflozin belongs to a class of medicines known as SGLT-2 inhibitors. It is used to treat type 2 diabetes. During the study, the doctors check whether participants have additional heart failure events like needing to go to the hospital again because of heart failure. The participants answer questions about how their heart failure affects their life. We then compare the results between the empagliflozin and placebo groups. The doctors also regularly check the general health of the participants.

NCT ID: NCT04156711 Completed - Clinical trials for Endothelial Dysfunction

Remote Ischemic Preconditioning in Patients Undergoing Acute Minor Abdominal Surgery

PUMAS
Start date: September 4, 2019
Phase: N/A
Study type: Interventional

This study examines if remote ischemic preconditioning in patients undergoing minor acute abdominal surgery (laparoscopic cholecystitis due to acute cholecystitis) is associated with a modulation of endothelial dysfunction. half of the patients will receive remote ischemic preconditioning prior to surgery, the other half will serve as controls.

NCT ID: NCT04156165 Completed - Obesity Clinical Trials

The Effect of High vs. Moderate Protein Consumption on Human Health

BEEF
Start date: November 1, 2019
Phase: N/A
Study type: Interventional

The study will be conducted as a parallel randomized controlled intervention trial, initiated by eight weeks rapid weight loss with one of two VLCDs, one week of reintroducing regular foods, and 12 weeks with one of two different ad libitum diets; in total 21 weeks. The study will be blinded for the statistician. Due to obvious different dietary intakes in the two diets, subjects cannot be blinded and neither the study personnel. As the study includes different dietary recommendations the registered clinical dietician advising the subjects cannot be blinded either. In total 110 overweight and obese volunteers will be included.

NCT ID: NCT04154306 Completed - Estrogen Deficiency Clinical Trials

Effects of Fermented Red Clover on Muscle Strength and Muscle Mass

Start date: November 1, 2019
Phase: N/A
Study type: Interventional

The project is designed as a randomized controlled, double-blinded, cross-over trial, including 10 healthy postmenopausal women consuming fermented red clover extract or placebo twice daily over a two-week period. After the first trial (two weeks), participants will undergo a two-week washout period, after which they will receive the opposite trial drink for two weeks. The trial period runs over six weeks. Before each of the two trial rounds, participants will meet in the laboratory and perform muscle strength tests (trial days 1 and 3). After each trial round (trial days 2 and 4), participants will meet fasting in the laboratory, and a blood test and a muscle biopsy will be taken initially. Next, the subject consumes the test drink (placebo or red clover extract) before the subject performs a strength training session with one leg. Right after the training session, the subject consumes a protein drink. Three hours after the protein drink, another muscle biopsy is taken. During the period from the protein drink to the final biopsy, the subject performs two muscle strength tests (respectively grip strength and maximum upper arm muscle strength (biceps)). The primary target parameter is muscle protein signaling measured in the muscle tissue samples using the western blotting method.

NCT ID: NCT04154046 Completed - Diabetic Foot Clinical Trials

Treatment of Impending Ulcers Associated With Hammer, Mallet and Claw Toe Deformities in the Diabetic Patient Setting

TODDIII
Start date: November 1, 2019
Phase: N/A
Study type: Interventional

Patients with diabetes, hammer, mallet and claw toes and impending ulcers associated with hammer mallet and claw toes will be randomized to tenotomy (cutting) of flexor tendons to the afflicted toes, done by needle and standard offloading or offloading alone. Impending ulcers are defined as callus or nail changes that are known pre-stages to ulcers. The effects of the surgery on incidence of ulcers associated with the named deformities, and rate of complications associated with the surgery.

NCT ID: NCT04154020 Completed - Diabetic Foot Ulcer Clinical Trials

Treatment of Ulcers Associated With Hammer, Mallet and Claw Toe Deformities in the Diabetic Patient Setting

TODDII
Start date: November 30, 2019
Phase: N/A
Study type: Interventional

1. Aim Patients with diabetes, hammer, mallet and claw toes and ulcers associated with the named deformities will be randomized to tenotomy (cutting) of flexor tendons to the afflicted toes, done by needle and standard offloading or offloading alone. The effects of the surgery on time to healing of ulcers associated with the named deformities, recurrence of the ulcers, and rate of complications associated with the surgery. In addition to this all patients gait and balance will be examined before start of the study, and after 3 months, to se if there is an effect of the surgery on patients gait and balance. 2. Method A prospective randomized clinical study, which means a study were patients will be allocated randomly to surgery and standard care or standard care alone. Patients will attend a total of up to 14 visits over a 12-month period. 3.

NCT ID: NCT04153435 Completed - Clinical trials for Heart Arrest, Out-Of-Hospital

Calcium for Out-of-Hospital Cardiac Arrest

COCA
Start date: January 20, 2020
Phase: Phase 2
Study type: Interventional

This is an investigator-initiated, multicenter, randomized, placebo-controlled, parallel group, double-blind, superiority trial of calcium during adult out-of-hospital cardiac arrest. 430 adult patients with out-of-hospital cardiac arrest receiving at least one dose of adrenaline will be enrolled. The primary outcome is sustained return of spontaneous circulation and key secondary outcomes include survival at 30 days and survival at 30 days with a favorable neurological outcome.

NCT ID: NCT04152252 Completed - Clinical trials for Out-Of-Hospital Cardiac Arrest

CPR Quality and Use of Feedback for OHCA

Start date: October 1, 2018
Phase:
Study type: Observational

The purpose of this study is to investigate the quality of cardio-pulmonary resuscitation(CPR) delivered by EMS professionals and whether this quality can be improved by implementing real-time feedback during the event and an oral post-event debriefing procedure based on the actual event performance data.